Skip to main content
OpenTrials

Clinical trial condition

Purpura, Thrombocytopenic

Explore clinical trials studying Purpura, Thrombocytopenic. Study availability and eligibility vary by location and protocol.

339 public trials 90 recruiting studies
Refine in advanced search Browse all conditions

Purpura, Thrombocytopenic trial results

Completed

Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

NCT01713738

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations
  • UCLA, Mattel Children's Hospital Los Angeles, California, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
View Trial Details
Completed

Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)

NCT00372892

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +15 more
Locations
  • St. Paul's Hospital Vancouver, British Columbia, Canada
  • Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada
  • McMaster Univerisity Hamilton, Ontario, Canada
  • Grand River Regional Cancer Centre Kitchener, Ontario, Canada
View Trial Details

Related conditions